Holdbrook Mark J. - Insider Non-Derivative Transactions at Tarsus Pharmaceuticals, Inc. (TARS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 20, 2023, Holdbrook Mark J.'s relationship to Tarsus Pharmaceuticals, Inc. (TARS) is Officer (V.P., Clinical Affairs), and currently has 3,191 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TARS insiders.
Data Source: SEC.
Holdbrook Mark J. - Insider Non-Derivative Transactions of TARS Common Stock
Holdbrook Mark J. - Insider Non-Derivative Transactions at TARS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 21, 2023 | Sell -- (Common Stock) | 198 | 12.61 | 3191 |
| Mar 18, 2023 | Sell -- (Common Stock) | 188 | 13.28 | 3389 |
| Mar 17, 2023 | Sell -- (Common Stock) | 187 | 13.43 | 3577 |
| Mar 16, 2023 | M -- (Common Stock) | 2653 | 0 | 3764 |